Frank Yocca is CSO at BioXcel Therapeutics, Inc. (BTAI). They have made 8 open-market trades across 1 company since 2018, most recently 2026-06-15.
CIK 0001733272
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $123K since 2018, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BTAI | 26,210 | $2K |
Shares reported on the most recent Form 4, priced at the 2026-06-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BTAI | SELL · 10b5-1 | 2026-05-20 | 2026-05-22 | $1.09 | $7K | +9.3% | +12.8% | -28.9% |
| BTAI | SELL · 10b5-1 | 2024-12-16 | 2024-12-17 | $0.35 | $153 | -6.0% | -11.4% | -63.5% |
| BTAI | SELL · 10b5-1 | 2024-10-03 | 2024-10-03 | $0.55 | $4K | +3.4% | +17.3% | -28.7% |
| BTAI | SELL · 10b5-1 | 2024-09-16 | 2024-09-17 | $0.69 | $245 | -5.8% | -10.9% | -36.5% |
| BTAI | SELL · 10b5-1 | 2024-06-17 | 2024-06-18 | $1.28 | $476 | -3.3% | +2.5% | -47.1% |
| BTAI | SELL · 10b5-1 | 2024-04-04 | 2024-04-08 | $2.64 | $3K | -1.2% | -17.8% | -58.1% |
| BTAI | SELL · 10b5-1 | 2023-03-15 | 2023-03-16 | $19.69 | $19K | -7.4% | +12.3% | +11.3% |
| BTAI | SELL | 2023-01-20 | 2023-01-24 | $30.00 | $1.5M | -3.6% | -3.1% | -27.3% |
| BTAI | SELL | 2021-03-15 | 2021-03-17 | $48.49 | $1.4M | -15.1% | -24.0% | -18.9% |
| BTAI | SELL | 2021-02-16 | 2021-02-18 | $57.65 | $1.6M | -6.2% | -17.5% | -44.0% |
| BTAI | SELL | 2021-01-25 | 2021-01-27 | $48.43 | $1.4M | +18.6% | +5.9% | -31.3% |
| BTAI | BUY | 2019-08-13 | 2019-08-14 | $8.67 | $114K | +8.0% | +21.4% | -48.3% |
| BTAI | BUY | 2018-12-03 | 2018-12-06 | $5.22 | $5K | -33.5% | +6.2% | +66.1% |
| BTAI | BUY | 2018-11-30 | 2018-11-30 | $5.20 | $2K | -16.1% | -22.5% | +70.3% |
| BTAI | BUY | 2018-11-29 | 2018-11-30 | $5.02 | $3K | -16.1% | -22.5% | +70.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.